The University of Chicago Header Logo

A critical review of ozanimod for the treatment of adults with moderately to severely active ulcerative colitis.

A critical review of ozanimod for the treatment of adults with moderately to severely active ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2022 May; 16(5):411-423.

View in: PubMed